About this scholarly article

Rimonabant: a selective blocker of the cannabinoid CB1 receptors for the management of obesity, smoking cessation and cardiometabolic risk factors by Gelfand, Eli V; Cannon, Christopher P is a scholarly article available to read on EtoBox.

Author

Gelfand, Eli V; Cannon, Christopher P

Publisher

Informa plc; Informa UK (Taylor & Francis); Taylor & Francis; Informa UK Limited; Informa Healthcare (ISSN 1354-3784)

Published

2006

Language

EN